CTOs on the Move

Biosense Webster

www.biosensewebster.com

 
Biosense Webster is offering you exposure to the best-in-class AF* practices through our Centers of Excellence program. Our Centers of Excellence provide you with the opportunity to fine tune your approach to PAF ablation by observing cases at
  • Number of Employees: 1K-5K
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details

Similar Companies

NextStep Arthropedix

NextStep Arthropedix is a medical device manufacturer focused on designing, developing, manufacturing, and distributing joint replacement implant and instrument products for hip and knee arthroplasty. This company is at the forefront of designing and manufacturing innovative implants characterized by the advantages of 3D printing technology.

Rubbermaid Medical

Rubbermaid Medical is a Huntersville, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Neurologica

Neurologica Corp. is a Danvers, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ASH TEMPLE

ASH TEMPLE Ltd. is a North York, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cvrx

CVRx® is a private company located in Minneapolis, Minnesota. The company has developed proprietary active implantable technology for the treatment of high blood pressure, also referred to as hypertension, and heart failure. The CVRx senior management and technical team have many years of experience commercializing implantable medical devices. The company is supported by an outstanding board of directors and a world-class scientific advisory board, which includes thought leading physicians and scientists in the field of hypertension and heart failure. CVRx has developed an implantable device that is designed to treat high blood pressure and heart failure. This new device called Barostim neo™ is designed to trigger the body`s own natural blood flow regulation system to treat high blood pressure and heart failure. CVRx has a strong intellectual property foundation, which will protect this unique technology. Barostim neo is CE marked in Europe for the treatment of hypertension patients. It is also CE marked in Europe for the treatment of heart failure. This product is currently under clinical evaluation in the United States and Canada for the treatment of high blood pressure and heart failure.